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Objective
Infants infected with HIV-1 fail to contain viral replication
as efficiently as adults. In the absence of antiretroviral
therapy (ART), opportunistic infections are common and
mortality rates range between 10–45% in HIV-infected
infants. To understand better the factors underlying rapid
infant HIV-1 progression, we examined HIV-specific CD8
T cells during the acute and chronic phases of infection.
Methods
HIV-infected pregnant Kenyan women were recruited
From 1999-2003. Other than antenatal prophylaxis, nei-
ther women nor infants received ART. Serial blood speci-
mens were obtained at delivery and months 1, 3, and
quarterly thereafter until death or two years. IFN-gamma-
producing CD8 T cells were quantified with ELISpot
assays using HLA-matched HIV-1 peptides as antigens. In
a subset of 7 infants, HIV-specific CD8 T cells were quan-
tified using class I HLA tetramers. Cellular phenotype was
described using multicolour flow cytometry; PBMC were
stained with tetramers and antibodies to cellular proteins.
Results
ELISpot assays were performed in 67 infants who acquired
HIV-1 before 1 month of age. HIV-specific IFN-gamma
release was detected 39% of infants at 1 month of age, and
58% at 3 months. The magnitude of responses to individ-
ual peptides was low, but within the range observed in
adults (median 230 HIVSFC/million PBMC, range 50–
2040 HIVSFC/million PBMC). High frequencies of HIV-
specific CD8 T cells were detected during acute infection
using tetramers (median 0.67%, range 0.045–3.8%). Over
time, the frequency of cells identified by tetramer staining
declined and the frequency of cells producing IFN-gamma
increased. Neither IFN-gamma production nor frequen-
cies of tetramer-stained cells correlated with HIV-1 viral
load. During acute HIV-1 infection, the phenotype of
infant HIV-specific CD8 T cells was similar to that
observed in adults; HIV-specific CD8 were activated,
CD27+CD28-, CD45RA-, CD95+ and contained low lev-
els of perforin. Similar to adults, during chronic infection
infant HIV-specific cells transitioned to a resting pheno-
type and increased expression of CD57, suggesting the
accumulation of senescent cells. In contrast to adults, the
majority of infant HIV-specific CD8 cells expressed CD95
during chronic infection, suggesting ongoing susceptibil-
ity to apoptosis. Also unlike adults, perforin declined to
very low or undetectable levels HIV-specific CD8 cells,
suggesting low cytotoxic potential.
Conclusion
The relatively poor control over HIV-1 viral replication
during infancy may be explained by differences in T cell
functionality between infants and adults, which may
include higher susceptibility to Fas-mediated apoptosis
and low cytotoxic potential.
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